Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.200
-0.100 (-2.33%)
Oct 23, 2026, 4:25 PM CEST
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.77 billion as of October 23, 2026. It is the 20,920th most valuable company in the world and the 135th biggest in Norway. Its market cap has increased by 44.04% in one year.
Market Cap
1.77B
Enterprise Value
1.96B
Revenue
1.64M
Global Rank
Country Rank
#135 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.77B, an increase of 280.30%. That is a compound annual growth rate of 49.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.77B | -4.54% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.15B |
| ArcticZymes Technologies ASA | 1.05B |
| Nykode Therapeutics AS | 1.04B |
| Lytix Biopharma ASA | 601.36M |
| Zelluna ASA | 537.49M |
| Oncoinvent ASA | 411.83M |
| SoftOx Solutions AS | 296.08M |
| Aqua Bio Technology ASA | 73.19M |